Successful treatment of inverse psoriasis with ustekinumab: a case report. (PubMed, Front Med (Lausanne)) - Sep 25, 2026 - "The patient received four subcutaneous injections of ustekinumab, and after 24 weeks of treatment, both skin lesions and pruritus showed marked improvement. Our experience suggests that ustekinumab may represent a novel therapeutic approach for this psoriasis subtype."
Journal • Dermatology • Immunology • Inflammation • Pruritus • Psoriasis
|
|
Jingjing Liu; Ting Yang; Yongjun Chen; Yunhan Hu
|